-
1
Using major histocompatibility complex (MHC) II expression to predict antitumor response to CD4 + lymphocyte depletion
Published 2025-02-01Subjects: Get full text
Article -
2
Characterization and functional analysis of chicken promyelocytic leukemia protein
Published 2024-12-01Subjects: Get full text
Article -
3
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
Published 2025-01-01Subjects: Get full text
Article -
4
Profiling MHC II immunopeptidome of blood‐stage malaria reveals that cDC1 control the functionality of parasite‐specific CD4 T cells
Published 2017-09-01Subjects: Get full text
Article -
5
Response of Leucocyte Populations in the Ileal Peyer'sPatch of Fetal Lambs Treated with Ferritin Per Os
Published 1995-01-01Subjects: Get full text
Article -
6
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer
Published 2025-06-01Subjects: Get full text
Article -
7
-
8
Associations between HLA-II variation and antibody specificity are predicted by antigen properties
Published 2025-06-01Subjects: Get full text
Article -
9
Susceptibility to and severity of tuberculosis infection in mice depends upon MHC-II-determined level of activation-inhibition balance in CD4 T-cells
Published 2025-08-01Subjects: “…MHC-II alleles…”
Get full text
Article -
10
Computational analysis of the functional impact of MHC-II-expressing triple-negative breast cancer
Published 2024-11-01Subjects: Get full text
Article -
11
Pathogenetic value of cell infiltrate in immunoinflammatory rheumatic diseases
Published 2021-12-01Subjects: Get full text
Article -
12
Autophagy, apoptosis, necroptosis, pyroptosis and netosis in pathogenesis of immune-inflammatory rheumatic diseases
Published 2022-07-01Subjects: Get full text
Article -
13
Nobiletin restores the intestinal barrier of HFD-induced obese mice by promoting MHC-II expression and lipid metabolism
Published 2025-01-01Subjects: “…Major histocompatibility complex class-II (MHC-II)…”
Get full text
Article -
14
Co‐Expression of MHC‐II and ANXA1: Mediators of PD‐1/PD‐L1 Therapy Resistance in Breast Cancer
Published 2025-08-01Subjects: Get full text
Article